CME Group (CME) Downgraded by BidaskClub to “Sell”

CME Group (NASDAQ:CME) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Wednesday.

Other research analysts have also issued research reports about the stock. Citigroup set a $205.00 price target on shares of CME Group and gave the stock a “buy” rating in a research note on Friday, February 15th. Berenberg Bank upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $220.00 price target for the company in a research note on Tuesday, November 20th. Deutsche Bank lifted their price target on shares of CME Group from $205.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, November 16th. Bank of America reiterated a “buy” rating and issued a $200.00 price target on shares of CME Group in a research note on Monday, November 5th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $204.00 price target on shares of CME Group in a research note on Wednesday, January 9th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $193.47.

CME Group stock traded up $1.29 during midday trading on Wednesday, hitting $175.59. 2,107,557 shares of the stock were exchanged, compared to its average volume of 1,798,384. CME Group has a fifty-two week low of $153.90 and a fifty-two week high of $197.08. The stock has a market cap of $59.24 billion, a P/E ratio of 25.75, a PEG ratio of 2.18 and a beta of 0.30. The company has a current ratio of 1.01, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.02. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same period last year, the business earned $1.12 earnings per share. The business’s revenue for the quarter was up 37.4% on a year-over-year basis. As a group, analysts forecast that CME Group will post 7.2 EPS for the current year.

In other news, CFO John W. Pietrowicz sold 17,960 shares of CME Group stock in a transaction on Wednesday, January 2nd. The shares were sold at an average price of $186.92, for a total value of $3,357,083.20. Following the transaction, the chief financial officer now directly owns 44,780 shares of the company’s stock, valued at approximately $8,370,277.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sean Tully sold 13,500 shares of CME Group stock in a transaction on Wednesday, December 12th. The shares were sold at an average price of $191.69, for a total transaction of $2,587,815.00. Following the completion of the transaction, the insider now directly owns 36,328 shares in the company, valued at $6,963,714.32. The disclosure for this sale can be found here. Insiders sold a total of 41,647 shares of company stock worth $7,868,428 over the last ninety days. Corporate insiders own 0.43% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. Resources Investment Advisors Inc. increased its stake in CME Group by 2,800.0% in the 4th quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock valued at $27,000 after buying an additional 140 shares during the period. Ruggie Capital Group acquired a new position in CME Group in the 4th quarter valued at $28,000. Smith Asset Management Group LP increased its stake in CME Group by 200.0% in the 4th quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock valued at $28,000 after buying an additional 100 shares during the period. Nelson Roberts Investment Advisors LLC purchased a new stake in shares of CME Group during the 4th quarter worth $33,000. Finally, Capital Financial Planning LLC purchased a new stake in shares of CME Group during the 4th quarter worth $40,000. 86.63% of the stock is currently owned by institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Article: Preferred Stock

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply